Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
viridi's Profile
Displaying 1-50 of 256 result(s).
CYDY CytoDyn Inc
06/23/2022 1:09:41 AM
0.059, N = 22. (1)
CYDY CytoDyn Inc
06/18/2022 12:23:05 PM
“He's been doing that for years a (1)
CYDY CytoDyn Inc
06/12/2022 5:14:36 PM
The report cited in your reply is f (1)
CYDY CytoDyn Inc
06/12/2022 12:12:32 PM
“according to one report, 50% of
CYDY CytoDyn Inc
05/30/2022 1:28:09 PM
The FDA guidance on meta analysis i (1)
CYDY CytoDyn Inc
05/30/2022 11:13:31 AM
I don’t think they have allowed d (1)
CYDY CytoDyn Inc
05/29/2022 2:43:54 PM
“depends on whether the FDA is re (1)
CYDY CytoDyn Inc
05/26/2022 4:58:32 PM
SK being “encouraged” in a PR ( (3)
CYDY CytoDyn Inc
02/12/2022 10:05:57 PM
“there better be a damn good reas (1)
CYDY CytoDyn Inc
08/11/2021 11:04:44 PM
Keep in mind that current managemen (9)
CYDY CytoDyn Inc
07/16/2021 2:21:31 PM
First, nasdaq doesn't go to the com (3)
CYDY CytoDyn Inc
07/16/2021 12:05:52 PM
Have Nader and Kelly formally annou (3)
CYDY CytoDyn Inc
07/16/2021 11:21:16 AM
NASDAQ won’t accept the company w (2)
CYDY CytoDyn Inc
07/08/2021 3:07:58 PM
If you truly believe that the short (7)
CYDY CytoDyn Inc
07/08/2021 1:44:47 PM
The only two things that drive the (3)
CYDY CytoDyn Inc
07/08/2021 1:40:26 PM
Nader was very clear, the purchase (2)
CYDY CytoDyn Inc
06/21/2021 4:45:34 PM
“Definitely sounds like goodbye t (1)
CYDY CytoDyn Inc
06/09/2021 1:21:48 PM
“This is actually one of the area
CYDY CytoDyn Inc
06/02/2021 12:28:13 AM
“I am quite surprised at how few (4)
CYDY CytoDyn Inc
05/31/2021 3:27:40 PM
I appreciated the video as well. In (2)
CYDY CytoDyn Inc
05/29/2021 6:44:18 PM
Figgs, if you haven’t already I s (1)
CYDY CytoDyn Inc
05/29/2021 3:17:22 PM
“Why is everyone saying waiting o (5)
CYDY CytoDyn Inc
05/29/2021 1:14:22 PM
“I think both sides are being pos (3)
CYDY CytoDyn Inc
05/27/2021 10:14:30 AM
Ohm, one of the arguments for the 7 (1)
CYDY CytoDyn Inc
05/26/2021 4:41:45 PM
"I will have to remind him that the (8)
CYDY CytoDyn Inc
05/25/2021 5:05:51 PM
" if the Company had management wit (6)
CYDY CytoDyn Inc
05/25/2021 1:39:23 PM
"Go look through past posts from pe (4)
CYDY CytoDyn Inc
05/25/2021 1:02:37 PM
"Which really points out the lie th (2)
CYDY CytoDyn Inc
05/25/2021 11:00:00 AM
“I am surprised by the overall ap (1)
CYDY CytoDyn Inc
05/25/2021 1:24:45 AM
The best defense from current manag (4)
CYDY CytoDyn Inc
05/19/2021 5:11:44 PM
Thank you for posting the Lalezari (5)
CYDY CytoDyn Inc
05/17/2021 3:18:09 PM
“Someone is dumping shares” Fif
CYDY CytoDyn Inc
05/17/2021 2:26:24 PM
You pose very important questions: (1)
CYDY CytoDyn Inc
05/17/2021 1:13:04 PM
I hope you are right, I fear you ar (1)
CYDY CytoDyn Inc
05/17/2021 12:39:18 PM
“Are you a pot stirrer?” What i (2)
CYDY CytoDyn Inc
05/17/2021 11:51:49 AM
“Or we wait for Brazil trial resu (3)
CYDY CytoDyn Inc
05/04/2021 11:54:25 PM
I’ll be curious to see what the a (1)
CYDY CytoDyn Inc
04/29/2021 4:46:15 PM
This is the best post I’ve seen o (1)
CYDY CytoDyn Inc
04/16/2021 5:15:24 PM
Ohm, by the same logic would LL the (1)
CYDY CytoDyn Inc
04/16/2021 4:59:09 PM
“This is CYDY’s opportunity to (2)
CYDY CytoDyn Inc
04/15/2021 1:09:55 PM
I think you are spot on. The next 1 (3)
CYDY CytoDyn Inc
04/13/2021 1:49:34 PM
.....and look at that, we found com
CYDY CytoDyn Inc
04/13/2021 1:27:26 PM
"ASKING for the Molecule and then s (2)
CYDY CytoDyn Inc
04/13/2021 1:03:02 PM
One would hope to have some rationa (2)
CYDY CytoDyn Inc
04/13/2021 1:01:09 PM
I understand that we can infer that (1)
CYDY CytoDyn Inc
04/13/2021 12:04:34 PM
A few questions about the Philippin (3)
CYDY CytoDyn Inc
04/09/2021 11:02:52 AM
Apology accepted.
CYDY CytoDyn Inc
04/09/2021 1:09:59 AM
“we don't know more than they do (5)
CYDY CytoDyn Inc
04/08/2021 9:25:21 PM
“Everyone talks about hitting a p (6)
CYDY CytoDyn Inc
04/08/2021 6:54:36 PM
LH symptoms are highly variable (as (3)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • WALOVI Launches Exciting New Beverages on Global Stage
  • Tesla's Model Y L: Are Fans Right to Be Concerned About Delays?
  • Join the Upcoming Investor Conference Webinar with KN
  • Tharimmune Experiences Significant Stock Surge Post Drug News
  • Metacon Reports Significant Revenue Growth in Recent Quarter
  • Navigating Market Shifts: Insights from Upcoming Events
  • Articulated Robots Set to Revolutionize Industries by 2032
  • NACON Showcases Exciting New Games at Gamescom 2025
  • Anoto Secures Bridge Loan to Propel INQ Smartpen Expansion
  • Insight into NB Private Equity Partners' Recent Share Buyback
  • OSB Group PLC's Significant Share Buyback Activity Announced
  • ICG Enterprise Trust Shares Buyback Details and Implications
  • Foresight Group Expands Its Share Buyback Initiative
  • Join KN's Investor Conference Webinar for Financial Insights
  • Novonesis Exhibits Robust Growth and Strategic Outlook for Future
  • Novonesis Sees Robust Growth and Strengthens Market Position
  • Novonesis Achieves Impressive 9% Organic Sales Growth
  • ROHM Unveils Groundbreaking Compact MOSFET for Fast Charging
  • Lowe's Positioning for Future Growth: A Valuable Investment
  • Novonesis Reports Strong Organic Growth and 2025 Outlook Adjustments
  • Geopolitical Tensions Shape Nvidia's Future in China Market
  • Nicox's NCX 470 Phase 3 Trial Showcases Efficacy in Glaucoma
  • Aker BP ASA Enhances Yggdrasil’s Potential with New Oil Find
  • Unveiling VISVISE: The Future of Game Art Design by Tencent
  • Nicox Showcases Promising Advances with NCX 470 in Glaucoma
  • Multitude Capital Oyj Reports Strong Growth in H1 2025
  • Icelandic Salmon Unveils Key Insights for Q2 and H1 Results 2025
  • Sampo plc's Remarkable Share Buyback: Insights and Impact
  • Endeavour Mining Successfully Executes Share Buyback Program
  • ALK's Q2 Growth Surges with 12% Revenue Increase
  • EDF’s Historic Bond Issuance: A Leap Towards Sustainable Energy
  • Gavin Newsom Responds to Beyond Inc.'s Store Strategy Reversal
  • Multitude Capital Releases Impressive H1 2025 Financials
  • Icelandic Salmon's Outlook for 2025: Key Insights and Analysis
  • ALK's Q2 Results Reflect Strong Growth and Positive Outlook
  • Kojamo's Financial Report Highlights: Growth and Outlook
  • Herantis Pharma Announces 1H 2025 Report with Key Developments
  • Systemair AB Reports First Quarter Results with Growth Insights
  • Aker BP ASA's Innovative Oil Discovery Boosts Industry Growth
  • GN Store Nord Reports Impressive Q2 2025 Financial Results
  • DNO ASA Reports Major Earnings Growth and Dividend Increase
  • Molecular Partners Welcomes Martin Steegmaier as New CSO
  • Vantage Drilling International's Upcoming Earnings Call Details
  • Kojamo plc Surges in Financial Performance in Mid-2025 Review
  • Kinepolis Cinemas Thriving with Blockbuster Success Insights
  • VGP Reports Strong Half-Year Performance with Record Growth
  • DNO ASA Announces Exciting Dividend Payment for Shareholders
  • Aegon's 2025 Mid-Year Results Showcase Positive Growth Trends
  • Molecular Partners Welcomes Martin Steegmaier as CSO for DARPin Innovation
  • Aegon's Half-Year Report Showcases Remarkable Financial Growth
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site